Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/12/2017 → 31/08/2020 |
Collaborative partners
- King's College London (lead)
- AstraZeneca plc
Funding
- MRC Medical Research Council: £479,321.00
MICA: SRC inhibition as a potential target for Parkinson's disease psychosis
- Mehta, Mitul (Primary Investigator)
- Ray Chaudhuri, Kallol (Co-Investigator)
- Ffytche, Dominic (Co-Investigator)
- Aarsland, Dag (Co-Investigator)
Project: Research